LT3630111T - Junginiai ir būdai, skirti bakterinių infekcijų gydymui - Google Patents

Junginiai ir būdai, skirti bakterinių infekcijų gydymui

Info

Publication number
LT3630111T
LT3630111T LTEPPCT/US2018/031593T LT18031593T LT3630111T LT 3630111 T LT3630111 T LT 3630111T LT 18031593 T LT18031593 T LT 18031593T LT 3630111 T LT3630111 T LT 3630111T
Authority
LT
Lithuania
Prior art keywords
compounds
treatment
methods
bacterial infections
infections
Prior art date
Application number
LTEPPCT/US2018/031593T
Other languages
English (en)
Inventor
Janelle Comita-Prevoir
Thomas Durand-Reville
Satenig GULER
Jan Romero
Mark Sylvester
Ruben Tommasi
Camilo VELEZ-VEGA
Xiaoyun Wu
Jing Zhang
Original Assignee
Entasis Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Entasis Therapeutics, Inc. filed Critical Entasis Therapeutics, Inc.
Publication of LT3630111T publication Critical patent/LT3630111T/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
LTEPPCT/US2018/031593T 2017-05-08 2018-05-08 Junginiai ir būdai, skirti bakterinių infekcijų gydymui LT3630111T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762502867P 2017-05-08 2017-05-08
PCT/US2018/031593 WO2018208769A1 (en) 2017-05-08 2018-05-08 Compounds and methods for treating bacterial infections

Publications (1)

Publication Number Publication Date
LT3630111T true LT3630111T (lt) 2022-03-10

Family

ID=62223332

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/US2018/031593T LT3630111T (lt) 2017-05-08 2018-05-08 Junginiai ir būdai, skirti bakterinių infekcijų gydymui

Country Status (26)

Country Link
US (1) US11046694B2 (lt)
EP (1) EP3630111B1 (lt)
JP (1) JP7058322B2 (lt)
KR (1) KR102611447B1 (lt)
CN (1) CN110709081B (lt)
AU (1) AU2018266640B2 (lt)
CY (1) CY1125340T1 (lt)
DK (1) DK3630111T3 (lt)
EA (1) EA038393B1 (lt)
ES (1) ES2907858T3 (lt)
HR (1) HRP20220231T1 (lt)
HU (1) HUE057592T2 (lt)
IL (1) IL270380B (lt)
LT (1) LT3630111T (lt)
MA (1) MA48743A (lt)
MX (1) MX385203B (lt)
MY (1) MY201377A (lt)
PE (1) PE20200333A1 (lt)
PH (1) PH12019502509A1 (lt)
PL (1) PL3630111T3 (lt)
PT (1) PT3630111T (lt)
SG (1) SG11201909443YA (lt)
SI (1) SI3630111T1 (lt)
SM (1) SMT202200110T1 (lt)
TW (1) TWI791018B (lt)
WO (1) WO2018208769A1 (lt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
EP4272831A3 (en) 2018-08-09 2024-02-21 Antabio SAS Diazabicyclooctanones as inhibitors of serine beta-lactamases
CN111675641B (zh) * 2020-06-04 2023-09-08 宁夏农林科学院农业资源与环境研究所（宁夏土壤与植物营养重点实验室） 单环β-内酰胺类化合物、单环内酰胺类化合物盐及其制备方法
US12410166B2 (en) 2021-05-07 2025-09-09 Ningxia Academy Of Agriculture And Forestry Sciences Sulfonylamidine substituted compounds and their use as beta-lactamase inhibitors
US11814385B2 (en) 2021-06-25 2023-11-14 University Of South Florida Small molecule inhibitors targeting Clostridioides difficile sporulation
CN122180683A (zh) * 2023-09-19 2026-06-09 恩塔西斯治疗公司 用于治疗细菌感染的化合物和方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE177099T1 (de) 1993-12-29 1999-03-15 Pfizer Diazabicyclische neurokinin antagonisten
FR2812635B1 (fr) 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
FR2825705B1 (fr) 2001-06-08 2005-05-20 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
FR2835186B1 (fr) 2002-01-28 2006-10-20 Aventis Pharma Sa Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases
US7439253B2 (en) 2002-12-06 2008-10-21 Novexel Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
FR2848210B1 (fr) 2002-12-06 2007-10-19 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens et inhibiteurs de beta-lactamases
US7507727B2 (en) * 2003-04-07 2009-03-24 Cylene Pharmaceuticals, Inc. Substituted quinobenzoxazine analogs and methods of using thereof
FR2914923B1 (fr) 2007-04-12 2013-06-14 Novexel Nouveaux composes heterocycliques azotes,leur preparation et leur utilisation comme medicaments antibacteriens.
JP5038509B2 (ja) 2008-01-18 2012-10-03 メルク・シャープ・エンド・ドーム・コーポレイション β−ラクタマーゼ阻害剤
FR2930553B1 (fr) 2008-04-29 2010-05-21 Novexel Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment inhibiteurs de beta-lactamases
EP2921559A1 (en) 2008-06-19 2015-09-23 Astra Zeneca Holding France Use of (1r,2s,5r) 1,6-diazabicyclo [3.2.1]octane-2-carboxamide, 7-oxo-6-(sulfooxy)-, monosodium salt as a diagnostic reagent for detecting serine beta-lactamases
FR2936798B1 (fr) 2008-10-03 2012-09-28 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens.
FR2937034B1 (fr) 2008-10-10 2012-11-23 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens
FR2936951B1 (fr) 2008-10-10 2010-12-03 Novexel Nouvelles combinaisons de composes heterocycliques azotes antibacteriens avec d'autres composes antibacteriens et leur utilisation comme medicaments
FR2951171A1 (fr) 2009-10-09 2011-04-15 Novexel Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation
EP2768503A1 (en) 2011-07-26 2014-08-27 Wockhardt Limited Pharmaceutical compositions comprising beta-lactam antibiotic, sulbactam and beta-lactamase inhibitor
CA2842777C (en) 2011-07-26 2015-12-29 Wockhardt Limited Pharmaceutical compositions comprising sulbactam and beta-lactamase inhibitor
BR112013028813B1 (pt) 2011-08-27 2020-10-20 Wockhardt Limited derivados de 1,6-diazabiciclo[3,2,1]octan-7-ona e composições farmacêuticas que os compreendem
CN103649088B (zh) 2011-08-30 2016-05-11 沃克哈特有限公司 1, 6- 二氮杂双环[3, 2, 1]辛- 7- 酮衍生物及其在治疗细菌感染中的用途
BR112014003476A2 (pt) 2011-09-13 2017-03-01 Wockhardt Ltd compostos contendo nitrogênio e seu uso
US8796257B2 (en) 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
EP2814483A2 (en) 2012-02-15 2014-12-24 Rempex Pharmaceuticals, Inc. Methods of treating bacterial infections
US8969570B2 (en) 2012-03-30 2015-03-03 Cubist Pharmaceuticals, Inc. Beta-lactamase inhibitors
TW201343645A (zh) 2012-03-30 2013-11-01 Cubist Pharm Inc １，３，４－□二唑及１，３，４－噻二唑β－內醯胺酶抑制劑
US8916709B2 (en) * 2012-03-30 2014-12-23 Cubist Pharmaceuticals, Inc. 1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors
JP2015512419A (ja) 2012-03-30 2015-04-27 キュービスト ファーマシューティカルズ， インコーポレイテッド イソオキザゾールβ−ラクタマーゼ阻害剤
AR090539A1 (es) 2012-04-02 2014-11-19 Astrazeneca Ab COMPUESTOS INHIBIDORES DE b LACTAMASA
HUE046893T2 (hu) 2012-05-30 2020-04-28 Meiji Seika Pharma Co Ltd Új ß-laktamáz inhibitor és eljárás elõállítására
ES2672100T3 (es) 2012-08-25 2018-06-12 Wockhardt Limited Derivados de 1,6-diazabiciclo[3,2,1]octano-7-ona y su uso en el tratamiento de infecciones bacterianas
NZ706734A (en) 2012-09-03 2016-05-27 Wockhardt Ltd Pharmaceutical compositions useful for the treatment or control of bacterial infections
CN104994860A (zh) 2013-02-06 2015-10-21 阿斯利康(瑞典)有限公司 用于治疗医院性肺炎的组合疗法
WO2014141132A1 (en) * 2013-03-14 2014-09-18 Naeja Pharmaceutical Inc. NEW HETEROCYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND β-LACTAMASE INHIBITORS
TWI690317B (zh) 2014-11-17 2020-04-11 英商安特西醫療有限公司 用於治療抗藥性細菌感染之組合療法
SG11201901658PA (en) 2016-09-16 2019-04-29 Entasis Therapeutics Ltd Beta-lactamase inhibitor compounds

Also Published As

Publication number Publication date
CN110709081A (zh) 2020-01-17
DK3630111T3 (en) 2022-03-14
MY201377A (en) 2024-02-21
HUE057592T2 (hu) 2022-05-28
WO2018208769A1 (en) 2018-11-15
AU2018266640B2 (en) 2022-03-03
MA48743A (fr) 2020-04-08
KR20200005586A (ko) 2020-01-15
MX385203B (es) 2025-03-14
KR102611447B1 (ko) 2023-12-06
EA201992370A1 (ru) 2020-03-10
CY1125340T1 (el) 2024-02-16
JP7058322B2 (ja) 2022-04-21
PT3630111T (pt) 2022-03-01
PH12019502509A1 (en) 2020-07-13
TWI791018B (zh) 2023-02-01
EP3630111B1 (en) 2021-11-24
IL270380B (en) 2022-06-01
PE20200333A1 (es) 2020-02-14
SG11201909443YA (en) 2019-11-28
SI3630111T1 (sl) 2022-05-31
CA3059773A1 (en) 2018-11-15
BR112019023130A2 (pt) 2020-05-26
US11046694B2 (en) 2021-06-29
US20200165251A1 (en) 2020-05-28
JP2020519687A (ja) 2020-07-02
NZ758200A (en) 2025-12-19
PL3630111T3 (pl) 2022-05-23
EA038393B1 (ru) 2021-08-20
MX2019013291A (es) 2020-01-15
CN110709081B (zh) 2023-09-22
ES2907858T3 (es) 2022-04-26
HRP20220231T1 (hr) 2022-04-29
AU2018266640A1 (en) 2019-11-07
SMT202200110T1 (it) 2022-05-12
TW201843152A (zh) 2018-12-16
EP3630111A1 (en) 2020-04-08

Similar Documents

Publication Publication Date Title
ZA202002069B (en) Novel mek-inhibitor for the treatment of viral and bacterial infections
IL277473A (en) Treatment and prevention of microbial infections
LT3496739T (lt) Kompozicijos ir būdai, skirti plaučių hipertenzijai gydyti
WO2015153889A3 (en) Materials and methods for the treatment of latent viral infection
HRP20190501T1 (hr) Monobaktam organski spojevi za liječenje bakterijskih infekcija
HRP20190580T1 (hr) Kombinirana terapija radi liječenja rezistentnih bakterijskih infekcija
IL271863B (en) Compounds and use thereof for the treatment of microbial infections
LT3416957T (lt) 6-heterociklil-4-morfolin-4-ilpiridin-2-ono junginiai, tinkami vėžio ir diabeto gydymui
LT3268374T (lt) Kv1.3 inhibitoriai ir jų medicininis pritaikymas
LT3377094T (lt) Susilpninto virulentiškumo bakterijos, skirtos piktybinių solidinių navikų gydymui
DK3630111T3 (en) Compounds and methods for treating bacterial infections
PT3565551T (pt) Métodos de tratamento de infeções bacterianas com uma combinação de vaborbactam e meropenem
IL281775A (en) Methods of treatment of infections using bacteria
SMT201900692T1 (it) Composizione per l'uso del trattamento delle infezioni batteriche
LT3630112T (lt) Regorafenibo ir nivolumabo derinys, skirtas vėžio gydymui
SG11202003009QA (en) Methods of treating bacterial infections
LT3630092T (lt) Kompozicija, kurios pagrindą sudaro vitaminas e arba jo esteris, skirta bakterijų ir grybelių bioplėvelėms gydyti
EP3448377A4 (en) METHODS FOR THE TREATMENT OF AN INFECTION
GB2558090B (en) Prevention and treatment for microbial infections
LT3364975T (lt) Trazodono ir gabapentino derinys, skirtas skausmo gydymui
LT3290436T (lt) Fenilalanino neturintis baltymas, skirtas fenilketonurijos gydymui
ZA201901948B (en) Heteroaryltrifluoroborate compounds for the treatment of mycobacterial infections
HK40036490A (en) Methods of treating bacterial infections
HK40026676A (en) Compounds and methods for treating bacterial infections
GB201804781D0 (en) Treating & preventing preventing microbial infections